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ABSTRACT  
Background: Cystatin C is mainly used as a biomarker of kidney function. It is freely filtered by 
glomerulus, and does not return to the blood stream or secreted by renal tubules. It has been 
suggested to be closer to the “ideal” endogenous marker.  
Objectives: To assess the plasma levels of cystatin c, creatinine clearance, blood HbA1C% and 
body mass index among Sudanese with type 2 Diabetes.  
Materials and methods: This is a case-control study conducted in diabetic centers in Khartoum 
state, Sudan, from March 2010 to November 2013. A total of 300 Sudanese patients with type2 
diabetes (49% males and 51% females) as a test group, and 150 healthy subjects (48%males and 
52%females) as a control group were enrolled in this study. Both groups were matched for gender 
and age. The plasma levels of Cystatin C, creatinine and blood HbA1c were measured using 
Nephelometry technique. Creatinine clearance was calculated for each participant. SPSS was used 
for analysis of data. 
Results: The means of the plasma levels of Cystatin C, HbA1c% and the body mass index (BMI) 
were significantly raised in the diabetic group compared to the control group (p<0.05).There is 
significant moderate negative correlation between Cystatin C and creatinine clearance (r=0.69, 
p=0.015) in the diabetic group, and there is a significant strong positive correlation between the 
plasma levels of Cystatin C and HbA1c%(r=o.78, p=0.044).  
Conclusion: The present data indicates that among Sudanese patients with Type 2 Diabetes 
Mellitus, plasma levels of Cystatin C are significantly raised and has a significant strong positive 
correlation with glycated haemoglobin % and a significant moderate negative correlation with 
creatinine clearance.  
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iabetes mellitus is a group of 
metabolic diseases characterized by 
high blood glucose levels, which 
result from defects in insulin secretion, action, 
or both1. Over  time,  Diabetes   can  lead   to   
blindness, kidney failure, and nerve damage. 
These  types   of   damage   are   the  result  of  
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damage to small vessels, referred to as micro 
vascular disease. Diabetes is also an 
important factor in accelerating hardening and 
narrowing of the arteries (atherosclerosis), 
leading to strokes, coronary heart disease, and 
other large blood vessel disease2. Diabetes 
affects approximately 17 million (about 8% of 
the population) in the United States. In 
addition, an estimated additional 12 million 
people in the United States have diabetes and 
don’t even know it. From an economic 
perspective, the total annual cost of diabetes 
in 1997 was estimated to be 98 billion dollars 
in the United States3. Diabetes is the third 
leading cause of death in the United States 
after heart disease and cancer4. Diabetes, the 
most common non-communicable disease in 
Sudan, is having an increasing impact on rates 
of morbidity and mortality. The spread of 
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sedentary lifestyles and adoption of western 
dietary habits that is high in refined 
carbohydrates and fat-are driving an increase 
in the number of people with obesity-related 
type 2 diabetes. Knowledge of the diabetes 
epidemic in Sudan is limited, and the most 
recent data come from a small-scale study 
indicated a prevalence of 3.4% but recent 
research estimates about four millions, around 
95% of whom have type 2 diabetes mellitus5.  
Cystatin C is a 122-amino acid, 13-KDa 
protein that is a member of the family of 
cysteine proteinase inhibitors. It is the product 
of a “housekeeping” gene expressed in all 
nucleated cells and is produced at a constant 
rate. The imbalance between Cystatin C and 
cysteine proteinases is associated with 
inflammation, renal failure, cancer, 
Alzheimer’s disease, multiple sclerosis and 
hereditary Cystatin C amyloid angiopathy6. 
Because of its small size and basic pH (9.0), 
Cystatin C is freely filtered by renal 
glomeruli. Cystatin C does not return to the 
blood stream and is not secreted by renal 
tubules it has been suggested to be closer to 
the “ideal” endogenous marker7.  
MATERIALS AND METHODS:  
This is an analytical, case-control and 
hospital- based study, that conducted in Jabir 
Abualizz and Almolazmeen diabetic centers 
in Khartoum State, Sudan, during the period 
from March 2010 to November 2013.A total 
of 300 Sudanese patients with type 2 diabetes 
mellitus were enrolled in this study as a test 
group, in contrast to 150 healthy volunteers as 
a control group. Both groups were matched 
for age and gender. Patients with type1 
diabetes, gestational diabetes, renal 
insufficiency, cancer, Alzheimer’s disease, 
multiple sclerosis and hereditary Cystatin C 
amyloid angiopathy were excluded from this 
study.  
A venous blood sample (4mls) was collected 
from each participant by standard procedures 
and divided into two containers, 2mls in 
EDTA container for HbA1c %(whole blood) 
and 2mls in heparin containers to ,which was 
centrifuged at 300rpm for 3mintutes to get 
plasma that kept at -20Co until used. The 
serum level of Cystatin C was measured using 
N latex Cystatin C (NCYSC) SIEMENS 
Nephelometry, and HbA1c for each sample 
was measured using Cobas system 
(SIEMENS Nephelometry). Plasma creatinine 
was measured using Jaffe reaction and then 
creatinine clearance for each participant was 
calculated using the Cockroft-Gault formula:  
Creatinine clearance (GFR estimation) =  
140 age weight  kg  1.23  0.85for female
Serum creatinine  mol/l 
 
The body mass index for each participant was 
calculated by measuring the height and the 
weight and using the following formula 
(BMI=Wt/heigt2). The Statistical Package for 
Social Science (SPSS version11.5) computer 
software was used for data analysis, 
independent t-test was used for comparison 
and the significant level was set at p≤0.05.  
RESULTS:  
This study was conducted on 300 Sudanese 
patients with type2 diabetes mellitus (49% 
males and 51% females) as a test group and 
150 healthy (non- diabetic) subjects (48% 
males and 52% female) as a control group. 
The test group and the control group were 
matched in term of gender and age. The mean 
age of the test group was 58.40±7.20 year and 
that of the control group was 56.8±10.0 year, 
(p=0.094).  
Table (1) shows means of the plasma levels of 
Cystatin C, creatinine clearance, HbA1c% 
and body mass index of the test group when 
compared with the control group.  
Figure (1) shows the correlation between the 
plasma Cystatin C and creatinine clearance. 
Figure (2) shows the correlations between the 
plasma levels of Cystatin C and HbA1c%, 
whereas Figure (3) shows the correlation 
between Cystatin C and body mass index. 
DISCUSSION:  
Cystatin C has low molecular weight 
(approximately 13.3 kilo Dalton), and it is 
measured from blood stream by the 
glomerular filtration in the kidneys. If kidney 
function and glomerular filtration rate decline,  
Mohammed NB et al.   Assessment of Plasma Cystatin C among Sudanese Patients with DM typeII 
© Sudan JMS Vol. 9, No.1. Mar 2014                41 
 
Table (1): Comparison of the serum levels of Cystatin C, creatinine clearance, HbA1c and body 































Figure (1): The relationship between creatinine clearance and serum cystatin C (r=-0.69; P=0.015) 
 
Figure (2): The relationship between HbAIC % and serum cystatin C (r=0.78; P=0.044) 
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the blood levels of Cystatin C raise. Plasma 
levels of Cystatin C are a more precise test  of 
kidney function than plasma creatinine8,9. In 
the present study the results show that the 
mean of the plasma levels of Cystatin C, 
creatinine clearance, blood HbA1c% and 
body mass index were raised. Figure (1) 
shows a moderate negative correlation 
between creatinine clearance and plasma 
Cystatin C levels, that means reduction of 
creatinine clearance, a marker of renal 
function, is associated with raised levels 
plasma of Cystatin C. Creatinine clearance in 
the diabetic group was significantly reduced 
compared to the healthy controls group and 
this could be due to the long standing effect 
of diabetes on the kidneys because the 
majority of the diabetic patients enrolled in 
this study have diabetes for more than 10 
years. Figure (2) which show strong 
correlation between HbA1c % plasma and 
cystatin C level. This means uncontrolled 
diabetes with abnormal raised glycated 
heamoglobin is associated with high Cystatin 
C plasma levels.  
In this study Cystatin C levels have 
significant weak negative correlation with 
body mass index in the diabetic group.  
Two large studies10,11 with consistent results 
found that Cystatin C is influenced by many 
variables (age, sex, body mass index, 
smoking, hypertension, coronary heart 
disease, C-reactive protein level) other than 
renal function alone, even after adjustment for 
kidney function. Both studies excluded 
patients with moderate and severe renal 
failure, and in both Cystatin C were highly 
correlated with age. In conclusion, although 
multiple factors in addition to renal function 
may influence cystatin C. The current study 
provides convincing evidence that Cystatin C 
may be more useful for detecting early renal 
impairment in type 2 diabetic patients than 
are creatinine and commonly employed 
creatinine-derived formulas10. These results 
are remarkable in light of data suggesting that 
Cystatin C is a useful indicator of the
 association of mild kidney dysfunction with 
increased risk for cardiovascular events, 
peripheral arterial disease, heart failure, and 
death11. Furthermore, recent studies suggest 
that very early renal failure may be 
considered the early marker of the underlying 
progressive kidney damage associated with 
diabetes.  
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